pentaacetylgitoxin

Known as: pengitoxin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1964-1988
01219641988

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
In a therapeutic study, 120 inpatients suffering from congestive heart failure were treated with a daily maintenance dose of 0.3… (More)
Is this relevant?
1988
1988
Color discrimination ability of 100 in-patients suffering from congestive heart failure and treated with digitoxin (D… (More)
Is this relevant?
1987
1987
In ten patients suffering from moderate to severe disturbances of liver function (hepatic cirrhosis, carcinomatous metastases of… (More)
Is this relevant?
1987
1987
The systolic time intervals (STI) corrected for changes in the heart rate, electromechanical systole (QS2c) and left ventricular… (More)
Is this relevant?
1986
1986
In six volunteers the pharmacokinetics of 16-acetyI-gitoxin (16AG, 0.5mg) administered intravenously (A1) and as an oral solution… (More)
  • figure 1
  • table I
Is this relevant?
1983
1983
The pharmacokinetics of pengitoxin has been studied in 28 healthy subjects after intravenous and oral administration. The mean… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1982
1982
Color discrimination ability of 53 patients with congestive heart failure and 32 healthy volunteers treated with digoxin… (More)
Is this relevant?
1978
1978
After oral administration of 3H-penta-acetyl-gitoxin (Pengitoxin W.H.O., Pentagit) 1.5 mg to four volunteers, serum radioactivity… (More)
Is this relevant?
1974